Morning Briefing
Summaries of health policy coverage from major news organizations
Pfizer Proposing $99 Billion Acquisition of British Competitor AstraZeneca
But news outlets note that the deal, which would allow Pfizer to escape the U.S. corporate tax rate, could be difficult to pull off. AstraZeneca says it rebuffed the American drug maker's advances earlier.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
